Go Deep
BioRem Inc.
BioRem Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,162 | 11.4 | 3.47 | 0.14 | 256.21 |
| Oct 2026 | 20,110 | 11.5 | 3.50 | 0.14 | 257.05 |
BioRem Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 15,688,667.0 | 6,816,883.0 | 16,941,355.0 | 11,252,966.0 |
| Net Profit | 1,981,517.0 | 201,344.0 | 2,877,144.0 | 1,157,539.0 |
| EPS | 0.1 | 0.0 | — | 0.1 |
BioRem Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 42,355,350.0 | 37,418,959.0 | 25,165,448.0 | 28,862,972.0 | — |
| Net Profit | 4,816,597.0 | 3,043,733.0 | 2,179,386.0 | 1,613,057.0 | — |
| EPS | 0.3 | 0.2 | 0.1 | 0.1 | — |
BioRem Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 33,576,437.0 | 28,510,585.0 | 24,076,012.0 | 20,730,060.0 | — |
| Total Liabilities | 18,650,653.0 | 17,885,502.0 | 17,356,227.0 | 16,209,507.0 | — |
| Total Equity | 14,925,784.0 | 10,625,083.0 | 6,719,785.0 | 4,520,553.0 | — |
Owes vs Owns
BioRem Inc. owed C$0.51 for every C$1 it owned in Jun 2026, down from C$0.78 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.51× | 0.56× | 0.63× | 0.72× | 0.78× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
BioRem Inc. Assets & Liabilities Breakdown (CAD millions)
What it owns — Dec 2025
Cash & short-term investments 34.3%Receivables 45.3%Inventory 4.1%Fixed assets (tangible) 5.4%Other assets 11.0%
How it's funded — Dec 2025
Short-term debt 1.8%Long-term debt 3.8%Payables 23.7%Other liabilities 26.3%Shareholders' equity 44.5%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 11.5 | 5.2 | 2.3 | 3.8 |
| Receivables | 15.2 | 14.9 | 14.1 | 12.2 |
| Inventory | 1.4 | 2.9 | 0.9 | 0.9 |
| Fixed assets (tangible) | 1.8 | 2.0 | 2.0 | 1.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 3.7 | 3.5 | 4.8 | 2.8 |
| Liabilities & equity | ||||
| Short-term debt | 0.6 | 0.6 | 0.5 | 1.3 |
| Long-term debt | 1.3 | 1.9 | 2.4 | 3.0 |
| Payables | 8.0 | 4.0 | 6.1 | 4.7 |
| Other liabilities | 8.8 | 11.4 | 8.2 | 7.2 |
| Shareholders' equity | 14.9 | 10.6 | 6.7 | 4.5 |
| Net tangible assets | 14.9 | 10.6 | 6.7 | 4.5 |
BioRem Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 7,638,579.0 | 3,685,096.0 | 490,033.0 | 1,444,914.0 | — |
| Investing Activities | -367,826.0 | -372,001.0 | -552,872.0 | -203,289.0 | — |
| Financing Activities | -767,053.0 | -572,040.0 | -1,329,231.0 | -951,798.0 | — |